Results for tag: "MOR208"

MOR208 is a monoclonal antibody drug used in the treatment of oncology. It is designed to target and block the activity of CD19, a protein found on the surface of certain types of cancer cells. By blocking CD19, MOR208 helps to reduce the growth and spread of cancer cells. It is used in combination with other cancer treatments, such as chemotherapy and radiation therapy. MOR208 is approved for use in the treatment of certain types of non-Hodgkin lymphoma, including diffuse large B-cell lymphoma and follicular lymphoma. It is also being studied for use in other types of cancer, such as chronic lymphocytic leukemia and multiple myeloma. MOR208 is marketed by several companies, including Novartis, Merck, and Roche. It is also available in generic form from several generic drug manufacturers. Show Less Read more